The Food and Drug Administration is asking retailers to remove a small number of acne creams from their shelves that contain ...
The Federal Trade Commission has walked back comments that a lack of resources is interfering with the agency’s ability to be ...
The drug and dollar stores channel finds footing despite inflation as consumers opt for convenience and private-label ...
Palantir (NASDAQ:PLTR) has built its success on the traction its AIP (artificial intelligence platform) has gained, and its commercial momentum ...
Palantir (NASDAQ:PLTR) has built its success on the traction its AIP (artificial intelligence platform) has gained, and its commercial momentum ...
William Blair analysts issued a cautionary note on Palantir Technologies (NASDAQ:PLTR), highlighting potential downside risk for the stock despite continued commercial momentum.
2d
Investor's Business Daily on MSNPalantir Stock Climbs As Wall Street Eyes New Artificial Intelligence Customers At AIPConPalantir stock climbed as analysts focused on potential new customers such as Walgreens at an artificial intelligence event called AIPCon.
The government's free at-home COVID-19 test distribution program is no longer accepting orders, its website says. Here's how to get tests in the meantime.
Latham describes it as the largest LBO of the year so far and the third-largest healthcare LBO of all time in the U.S. & ...
Latham describes it as the largest LBO of the year so far and the third-largest healthcare LBO of all time in the U.S. & ...
There are plenty of reasons to be skeptical that private equity will help Walgreens get out of turbulent times.
CVS is looking to grow itself by shrinking. The pharmacy chain is opening around a dozen stores this year that are about the half the size of its traditional layout and have only a pharmacy — ditching ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results